J. Pharm. Technol. Res. Manag.

Cold Chain: A Lynchpin of National Immunization Program

Ashok Peepliwal


Vaccine, National Immunization Program (NIP), Freeze Sensitivity, Heat Sensitivity, Primary healthcare centers (PHCs), eVIN (Electronic Vaccine Intelligent Network)

PUBLISHER The Author(s) 2017. This article is published with open access at www.chitkara.edu. in/publications

Cold chain management (CCM), a lynchpin of National Immunization Program (NIP) is to deliver the vaccines or other immunological products/ vaccines to right people, at right place, and in right time ineffective manner under the controlled conditions to ensure its potency. To comply it, CCM is required with standardized equipment’s and standard procedures to transport the immunological products to ensure the availability of high-quality vaccines and immunization-related materials to all levels of the program. It is vital to ensure accurate implementation of pertinent strategies focusing on vaccine storage; transportation, immunization, safety, management & monitoring. If the CCM is managed properly, the program costs can be reduced markedly without sacrificing the potency of product. Apart from that, high and unwanted vaccine wastage rates are due to poorly managed planning resulting into significant variation in operation program cost, improper management of waste with the negative impact on public health. The review enlightens on how vaccines are stored, transported and monitored to sustain immunological products/vaccines integrity throughout the way of their transportation emphasizing on the various equipment’s and logistic needs to cover the entire cold chain management rigorously till the reach of target population child/mother at the primary healthcare centers(PHCs).

Page(s) 77–104
URL http://dspace.chitkara.edu.in/jspui/bitstream/1/831/3/07_JPTRM_Peepliwal.pdf
ISSN Print : 2321-2217, Online : 2321-2225
DOI 10.15415/jptrm.2017.51007
  • A critical leap to polio eradication in India (2006). UNICEF Pub 2003. Available from:URL: http:// w3.whosea.org/n/Section1226/immeeting/aefi/documents/CommunicationforImmunization/ AcriticalleaptoPolioEradication.pdf
  • Afsar A, Kartoglu U. (2006) Vaccine stock management: guidelines for immunization and vaccine store managers. Geneva, 2006. WHO/IVB/06.12 Available from: www. whqlibdoc.who.int/hq/2006/WHO_IVB_ 06.12_eng.pdf
  • Aggarwal, A, Singh A. J. (1995) Evaluation of cold chain system in rural areas of Haryana, Indian Pediatr, 32(1), 31–34.
  • Aggarwal, K., Kannan, A.T., Kumar P. (2002) Study of operational aspects of pulse polio booths during Intensified Pulse Polio Immunization Campaign in assembly segments of East Delhi, J Commun Dis, 34, 215–220.
  • Agrawal, D. K. (2005) Textbook of Logistics and Supply Chain Management, MacMillanIndia Ltd., New Delhi.
  • Bachani, D., Bansal, R. D. (1990) Logistics management in Universal Immunization Programme, Indian J Public Health, 34, 179–84.
  • Baldiwala, Q. (2001) Developing a global supply chain, Logistics Spectrum 35, 25–29.
  • Bell, K. N. (2001) Risk factors for improper vaccine storage and handling in private provider offices, Pediatrics, 107(6), 100–105. https://doi.org/10.1542/peds.107.6.e100
  • Bishara R. Global perspectives in regulatory oversight. (video). Extensio et Progressio, Authentic e-Learning and Global Learning Opportunities. Available from: www.vimeo. com/51441317
  • Burgess, M.A., McIntyre P.B. (1999) Vaccines and the cold chain: is it too hot...or too cold, Med J Aust, 171–182.
  • Burton A, Monasch R, Lautenbach B, et al. (2009) WHO and UNICEF estimates of national infant immunization coverage: methods and processes, Bull World Health Organ, 87, 535–541. https://doi.org/10.2471/BLT.08.053819
  • Chen, D., Kristensen, D. (2009) Opportunities and challenges of developing thermo-stable vaccines, Expert Rev Vaccines, 8, 547–557. https://doi.org/10.1586/erv.09.20
  • Chudasama, R. K., et al. (2009) Evaluation of Intensive Pulse Polio Immunization in the South Gujarat Region of India, The Internet Journal of Pediatrics and Neonatology, 9(2), 213–217.
  • Dellepiane, N., Griffiths, E., Milstien, J.B. (2000) New challenges in assuring vaccine quality, Bull World Health Organ, 78(2), 155–162.
  • Dietz, V., Galazka, A., et al. (1997) Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems, Bull World Health Organ 75(1), 81–93.
  • Dietz, V., Milstien, J.B., Van Loon F., et al. (1996) Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus, Bull World Health Organ, 74(6), 619–628.
  • Dr. Bob (2014) Los Angeles Times, “Vaccination controversy swirls around O.C.’s ‘Dr. Bob’,” Sept. 6, 2014.
  • Erica W. et. al. (2004) Synopsis Preventing cold chain failure: vaccine storage and handling. CMAJ, 171(9), 1050–1055 doi: 10.1503/cmaj.1041565 https://doi.org/10.1503/cmaj.1041565
  • First study validating the shake test with 100% positive predictive value. World Health Organization. Shake and tell– video article. Available from: www.vimeo. com/8381355.
  • Gazmararian, J.A., Oster, N.V., Green, D.C., et al. (2002) Vaccine storage practices in primary health care physician offices, Am J Prev Med 23(4), 246–253. https://doi.org/10.1016/S0749-3797(02)00512-3
  • Geneva, World Health Organization, 1989 (unpublished document BS/89.1614, available on request from the Global Programme for Vaccines and Immunization, World Health Organization, 1211 Geneva 27, Switzerland).
  • Goel, N. K, et al. (2004) Evaluation of cold chain system in Chandigarh during PPI campaign 2001–2002, Indian J Public Health, 48, 200–204.
  • Goel, N.K., Swami H.M., Bhatia S.P. (2004) Evaluation of cold chain system in Chandigarh during PPI campaign 2001–2002, Indian J Public Health, 48, 200–204.
  • Hanjeet, K. et al. (1996) Evaluation of cold chain monitoring in Kelantan, Malaysia, Bull World Health Organ, 74, 391–397.
  • Health Canada. Guidelines for temperature control of drug products during storage and transportation (GUI-0069). Available from: www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/compli-conform/gmp-bpf/docs/GUI-0069- eng. pdf.
  • Hinman A. (1999) Eradication of vaccine preventable diseases, Annu Rev Public Health; 20, 241–249. https://doi.org/10.1146/annurev.publhealth.20.1.211
  • Hinman, A. (1999) Eradication of vaccine preventable diseases, Annu Rev Public Health, 20, 211–229. http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/25-of- vaccines-go-waste-due-to-lack-of-cold-chain/articleshow/53001625.cms. https://doi.org/10.1146/annurev.publhealth.20.1.211 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=203, retrieved 5/22/2012 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=205.50, retrieved 5/22/2012 http://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ ucm073857.htm, retrieved 6/14/2012 http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/ Step4/Q1A_R2__Guideline.pdf http://www.pharmaceuticaloutsourcing.com/pdf/ POD001_054E_Bristol-Myers.pdf, retrieved 5/22/2012 (“Preserving the Cool Chain,” Mary Simpson, Edith Penxten, Elie Dechesne,)
  • Jain, R., et al. (2003) Cold chain monitoring of OPV at transit levels in India: correlation of VVM and potency status, Biologicals 31, 237–44. https://doi.org/10.1016/S1045-1056(03)00061-7
  • Jezek J, Chen D, Watson L, et al. (2009) A heat-stable hepatitis B vaccine formulation, Hum Vaccin, 5(8), 529–535. https://doi.org/10.4161/hv.5.8.8600
  • Kaplan, S., Garrick, B.J. (1981) On the quantitative definition of risk. Risk Anal 1, 11–27. https://doi.org/10.1111/j.1539-6924.1981.tb01350.x
  • Kartoglu, U., et al. (2012) ensuring the optimal potency of vaccines: effective vaccine management practices). In: Badur S, Bakir M, editors. AsiKitabi (book of vaccines). Akademi Publishing, Turkey, 169–189.
  • Kartoglu, U., et al. (2010) Validation of the shake test for detecting freeze damage to adsorbed vaccines, Bull World Health Organ, 88, 624–631. https://doi.org/10.2471/BLT.08.056879
  • Kartoglu, U., Nelaj, E., Maire, D. (2010) Improving temperature monitoring in the vaccine cold chain at the periphery: an intervention study using a 30-day electronic refrigerator temperature logger (Fridge-tag), Vaccine, 28, 4065–4072. https://doi.org/10.1016/j.vaccine.2010.03.076
  • Kurzatkowski W, Kartoglu U, Staniszewska M, et al. (2013) Structural damages in adsorbed vaccines affected by freezing, Biologicals, 41(2), 71–76. https://doi.org/10.1016/j.biologicals.2011.10.011
  • L. Yuan, S. et al. (1995) Vaccine storage and handling: Knowledge and practice in primary care physicians’ offices, Can Fam Physician, 41, 1169–1176.
  • Le Tailec, D., (2009) et al. CervarixTM, the GSK HPV-16/HPV- 18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions, Hum Vaccin, 5, 67–74.
  • Levine, O.S., et al. (2011) The future of immunisation policy, implementation, and financing. Lancet, 378(9789), 439–448. https://doi.org/10.1016/S0140-6736(11)60406-6
  • Levinson DR. Vaccines for children program: vulnerabilities in vaccine management. Department of Health and Human Services, Office of Inspector General. 2012. OEI-04-10- 00430 Available from: www.oig.hhs.gov/oei/reports/oei-04- 10-00430.pdf • Documenting how poorly cold chain is maintained in an industrialized country.
  • Lewis, P.R., Reimer R.F., Dixon A.J. (2001) Evaluating the efficacy of vaccine storage in the general practice setting, Aust N Z J Public Health Dec, 25(6), 547–550.
  • Lugosi, L., Battersby, A. (1990) Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe, Bull World Health Organ, 68, 431–43.
  • Mallik S., et al. (2011) Assessing cold chain status in a metro city of India: an intervention study, African Health Sciences, 11(1), 128–133.
  • Matthias DM, Robertson J, Garrison MM, et al. Freezing temperatures in the vaccine cold chain: a systematic review. Vaccine 2007;25:3980-6 • Best systematic review documenting the freezing events in the vaccine cold chain. https://doi.org/10.1016/j.vaccine.2007.02.052
  • McColloster P.J. (2011) US vaccine refrigeration guidelines: loose links in the cold chain, Hum Vaccin, 7, 574–575. https://doi.org/10.4161/hv.7.5.14489
  • Milstien J, Kartoglu U, Zaffran M. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006. Available from: www.whqlibdoc.who.int/hq/2006/WHO_IVB_06.10_ eng.pdf.
  • Ministry of Health & Family Welfare, Government of India. (2003) Cold Chain Management for Vaccine Handler. New Delhi: Dept. Health & Family Welfare, Govt. of India.
  • Mishra, N., Kumar, S. (2016) Determinants of Immunization: A Study from Uttar Pradesh using Multinomial logistic Regression Approach, Sch. J. App. Med. Sci. 4(3), 990–993.
  • Murhekar, M.V., Dutta, S., Kapoor, A.N., et al. (2013) Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states, Bull World Health Organ, 91, 906–913. https://doi.org/10.2471/BLT.13.119974
  • Nagdeve D, Bharti D. (2006) Urban-rural differentials in maternal and child health in Andhra Pradesh, India Rural and Remote Health 2003. Available from: URL: http://e-jrh.deakin .edu.au/articles/subviewnew.asp?ArticleID=146.
  • National Health and Medical Research Council (2008). The Australian Immunisation Handbook 9th Ed. Commonwealth of Australia. View this reference at http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/handbook-home.
  • Ortega, M. P., et al. (2002) Vaccine storage cold chain at primary care centers in one area of Madrid: keeping the chain intact and degree of knowledge, Rev EspSaludPublica, 76(4), 333–346.
  • Pande, R. P. (2003) Selective gender differences in childhood nutrition and immunization in rural India: the role of siblings, Demography 40, 395–418. https://doi.org/10.1353/dem.2003.0029
  • Parenteral Drug Association (2007) Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Bethesda (MD) Parenteral Drug Association (PDA) PDA J Pharm Sci Technol, Report No. 39.
  • Patil A.V. et al. (2002) Current health scenario in rural India, Aust J Rural Health 10, 129–131. https://doi.org/10.1111/j.1440-1584.2002.tb00022.x
  • Sachdeva, S., Datta U. (2010) Status of vaccine cold chain maintenance in Delhi, India, India J Med Microbiol 28, 184–185. https://doi.org/10.4103/0255-0857.62507
  • Samant, Y. (2007) Evaluation of the Cold-Chain for Oral Polio Vaccine in a Rural District of India, Public Health Rep, 122(1), 112–121.
  • Samant, Y., et. al. (2007) Relationship between vaccine vial monitors and cold chain infrastructure in a rural district of India. Rural and Remote Health 7 (online), 2007: 617. Available from: http://www.rrh.org.au.
  • Schondorf, I., et al. (2007) Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: a controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months, Vaccine 25, 1175–1182. https://doi.org/10.1016/j.vaccine.2006.10.022
  • Srinivasan R. (2005) Healthcare in India—2005; issues and prospects: http://planningcommission.nic.in/reports/sereport/ser/vision2025/health.pdf.
  • Stamatis D.H. (2003) Failure mode and effect analysis. FMEA from theory to execution. American Society for Quality; 2003.
  • Sudarshan, M.K., Sundar, M., Girish, N., Patel, N.G. (1994) An evaluation of cold chain system for vaccines in Bangalore, Indian J Pediatr 61, 173–178. https://doi.org/10.1007/BF02843611
  • Tembleque M.D.S., et.al. (2013) Vaccines and recommendations for their use in inflammatory bowel disease World J Gastroenterol. 19(9), 1354–1358. doi: 10.3748/wjg.v19.i9.1354. https://doi.org/10.3748/wjg.v19.i9.1354
  • Thakker, Y., Woods, S. (1992) Storage of vaccines in the community: weak link in the cold chain? BMJ 304(6829), 756–758. https://doi.org/10.1136/bmj.304.6829.756
  • Umit, K., Milstien, J. (2014) Tools and approaches to ensure quality of vaccines throughout the cold chain, Expert Rev. Vaccines 13(7), 843–854. https://doi.org/10.1586/14760584.2014.923761
  • United Nations/AGECC. Energy for a sustainable future: summary report and recommendations, 2010. New York. Available from: www.un.org/wcm/webdav/ site/climatechange/shared/Documents/ AGECC%20summary%20 report%5B1% 5D.pdf.
  • Wirkas, T., et al. (2007) A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries, Vaccine, 25, 691–697. https://doi.org/10.1016/j.vaccine.2006.08.028
  • World Health Organization (2006). Temperature sensitivity of vaccines. View this reference at http://www.who.int/vaccines-documents/DocsPDF06/847.pdf.
  • World Health Organization. Children: reducing mortality (2012) WHO Fact sheet no. 178.. Available from: www.who.int/mediacentre/factsheets/fs178/en/.
  • World Health Organization. Establishing and improving primary and intermediate vaccine stores. Geneva: 2002; WHO/V&B/ 02.34.
  • orld Health Organization. Guidelines on stability evaluation of vaccines. Expert committee on biological standardization, technical report series 57th report. Geneva 2006;962:annex3.
  • World Health Organization. Model guidance for the storage and transport of time- and temperature sensitive pharmaceutical products. WHO Expert committee on specifications for pharmaceutical preparations 45th report. WHO Technical Report Series. No.961;2011. Annex9.
  • World Health Organization. Requirements for yellow fever vaccine. Expert committee on biological standardization, technical report series 46th Report. Geneva 1998. 840:Annex2. Available from: www. whqlibdoc.who.int/trs/WHO_TRS_872.
  • World Health Organization. Vaccines, Immunization and Biologicals. The cold chain (Cited 2006 Oct 18), November 26, 2002. www.logistics week.com July 2015 www.who.int/ biologicals/areas/vaccines/controlled temperaturechain/en/- Temperature controlled chain (CTC).
  • Yuan, L. et al. (1995) Vaccine storage and handling. Knowledge and practice in primary care physicians’ offices. Can Fam Physician. 41, 1169–1176